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Use of Medicare Diagnosis and Procedure Codes to Improve
Detection of Surgical Site Infections following Hip Arthroplasty,
Knee Arthroplasty, and Vascular Surgery
Michael S. Calderwood, MD;1 Allen Ma, PhD;2 Yosef M. Khan, MBBS, MPH;3 Margaret A. Olsen, PhD, MPH;4
Dale W. Bratzler, DO, MPH;2,5 Deborah S. Yokoe, MD, MPH;6 David C. Hooper, MD;7 Kurt Stevenson, MD, MPH;3
Victoria J. Fraser, MD;4 Richard Platt, MD, MSc;1 Susan S. Huang, MD, MPH;8
for the CDC Prevention Epicenters Program
objective. To evaluate the use of routinely collected electronic health data in Medicare claims to identify surgical site infections (SSIs)
following hip arthroplasty, knee arthroplasty, and vascular surgery.
design. Retrospective cohort study.
setting. Four academic hospitals that perform prospective SSI surveillance.
methods. We developed lists of International Classification of Diseases, Ninth Revision, and Current Procedural Terminology diagnosis
and procedure codes to identify potential SSIs. We then screened for these codes in Medicare claims submitted by each hospital on patients
older than 65 years of age who had undergone 1 of the study procedures during 2007. Each site reviewed medical records of patients
identified by either claims codes or traditional infection control surveillance to confirm SSI using Centers for Disease Control and Prevention/
National Healthcare Safety Network criteria. We assessed the performance of both methods against all chart-confirmed SSIs identified by
either method.
results. Claims-based surveillance detected 1.8–4.7-fold more SSIs than traditional surveillance, including detection of all previously
identified cases. For hip and vascular surgery, there was a 5-fold and 1.6-fold increase in detection of deep and organ/space infections,
respectively, with no increased detection of deep and organ/space infections following knee surgery. Use of claims to trigger chart review
led to confirmation of SSI in 1 out of 3 charts for hip arthroplasty, 1 out of 5 charts for knee arthroplasty, and 1 out of 2 charts for
vascular surgery.
conclusion. Claims-based SSI surveillance markedly increased the number of SSIs detected following hip arthroplasty, knee arthroplasty,
and vascular surgery. It deserves consideration as a more effective approach to target chart reviews for identifying SSIs.
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The Centers for Disease Control and Prevention (CDC) has
estimated that nearly 300,000 surgical site infections (SSIs)
occur annually in US hospitals, leading to several billion dol-
lars in direct medical costs that are potentially preventable.1,2
These numbers may be an underestimate for several reasons.
First, individual hospitals commit varying degrees of effort
and resources to SSI surveillance, leading to inconsistent and
incomplete identification of SSIs. Second, the majority of SSIs
occur after hospital discharge, with the result that many are
neither reported nor linked in a surveillance system to the
original procedure.3,4
These inconsistencies in SSI detection make interhospital
comparisons of SSI rates problematic, and a more standard-
ized approach to SSI surveillance is needed in light of the
increasing number of legislative mandates for the public re-
porting of SSIs. Payer-based claims data containing diagnosis
and procedure codes are standardized and routinely collected.
In addition, payer claims track the full spectrum of healthcare
utilization, regardless of where care is sought. While the value
of claims data varies widely by the outcomes being studied,
evidence continues to mount about the usefulness of these
data for SSI detection. Surveillance based on routinely col-
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lected health data, including inpatient and outpatient claims,
has repeatedly been shown to increase identification of SSIs
when compared with traditional surveillance by hospital in-
fection prevention programs.5-10 These demonstrations of in-
creased detection include the use of Medicare claims data to
identify SSI following coronary artery bypass graft (CABG)
surgery.11,12
We explored the potential usefulness of coded diagnoses
and procedures captured in claims as the primary trigger for
chart review aimed at identifying SSIs after hip arthroplasty,
knee arthroplasty, and vascular surgery. These are 3 of the 7
high-volume procedures targeted by the Surgical Care Im-
provement Project (SCIP), a national partnership of public
and private organizations focused on the reduction of surgical
complications.
methods
We conducted retrospective cohort studies at 4 hospitals to
evaluate the performance of diagnosis and procedure codes
used to trigger chart review for SSI detection following hip,
knee, and vascular surgery. The cohorts included non–health
maintenance organization (HMO) Medicare recipients older
than 65 years of age who underwent 1 of the SCIP-targeted
hip arthroplasty, knee arthroplasty, or vascular surgery pro-
cedures between January 1, 2007, and December 31, 2007.13
We excluded HMO (Medicare Advantage) participants be-
cause claims are not required for reimbursement in this
group. We used 2007 Medicare data to assure that greater
than 99% of relevant Medicare claims had been finalized
when we accessed the data in November 2010.
We excluded patients who had another SCIP procedure on
the day of their index surgery or in the 60 days before surgery
to reduce uncertainty in attributing an SSI to a specific pro-
cedure. SCIP has targeted high-volume surgeries with a sig-
nificant risk of surgical complication, including the 3 pro-
cedures in our study plus CABG, other cardiac surgery, colon
surgery, and hysterectomy. Patients with multiple surgical
dates for the same SCIP procedure during their index hos-
pitalization were also excluded. For patients who underwent
another SCIP procedure within the postoperative surveillance
period, we looked for evidence of SSI through the date of
the second surgery. Finally, we excluded patients who had
diagnosis or procedure codes suggestive of infection at the
surgical site on the day of surgery or in the 30 days before
surgery.
We developed lists of procedure-specific SSI indicator codes
to identify possible SSIs following each procedure (appendix).
To maximize sensitivity and to account for differential use of
codes by hospitals, these lists were intended to include all
codes that might be used in the presence of an SSI, even if
the specificity of certain individual codes was expected to be
low. We did, however, remove cellulitis codes (ICD-9 682.x)
due to low discriminatory values, since they flagged a high
enough proportion of charts to suggest detection of infection
due to other sources. In addition, CDC/National Healthcare
Safety Network (NHSN) criteria specifically state that cellu-
litis is not sufficient to qualify as an SSI. We included Inter-
national Classification of Diseases, Ninth Revision (ICD-9),
and Current Procedural Terminology (CPT) diagnosis and
procedure codes submitted under Medicare Part A from in-
patient and outpatient facilities as well as Medicare Part B
physician claims.
We applied the list of vascular SSI indicators to the period
of 60 days following a vascular procedure and the lists of hip
and knee SSI indicators to the period of 365 days following
hip and knee arthroplasty. CDC recommends SSI surveillance
for 30 days following surgeries without prosthetic material
and 365 days following surgeries with prosthetic material.
This longer surveillance window of 365 days applies to the
diagnosis of deep incisional and organ/space SSIs, while su-
perficial incisional SSIs are included only if they occur within
30 days following surgery. While some vascular surgeries do
use prosthetic material (eg, non-human-derived graft), there
is no way to infer this information from the procedure code.
We chose a 60-day rather than a 30-day window for vascular
SSI surveillance, since healthcare utilization may occur after
the onset of symptoms. We opted not to screen beyond 365
days following hip and knee arthroplasty, on the basis of data
showing that the majority of SSIs following these procedures
occur within 90 days.14
The study was performed in collaboration with the
Oklahoma Foundation for Medical Quality acting in its ca-
pacity as a national hospital quality resource center for Med-
icare’s Quality Improvement Organization Program. The
Oklahoma Foundation for Medical Quality identified Med-
icare patients at each participating hospital who had under-
gone a qualifying procedure, and it further identified those
with an SSI indicator code in the surveillance period following
that procedure.
This study was conducted through an interagency agree-
ment between the Centers for Medicare and Medicaid Ser-
vices and the CDC. Institutional Review Board approval was
received at all participating CDC Prevention Epicenter sites.
The infection prevention program at each hospital was sent
a list of Medicare patients who had undergone a study pro-
cedure at their hospital and who had been flagged by a pro-
cedure-specific SSI indicator code. Personnel at the receiving
hospital compared these patients with their own cases cap-
tured by traditional infection control surveillance. An expe-
rienced infection control researcher then reviewed the full-
text medical record for all cases identified by either traditional
surveillance or claims-based surveillance, using CDC/NHSN
criteria to confirm the presence of an SSI.15 While the re-
searchers were not blinded as to whether each case was iden-
tified by traditional surveillance or claims-based surveillance,
the same criteria were used to assess all cases. Each hospital
reviewed all inpatient records and any available outpatient
records from their medical center.
We assessed the sensitivity of both traditional infection
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table 1. Patient Characteristics by Procedure
Hip arthroplasty Knee arthroplasty Vascular surgery
No. of eligible procedures 576 724 366
Age, median (IQR) 76 (70–82) 74 (69–78) 75 (70–79)
Sex, male 224 (39) 269 (37) 237 (65)
Comorbidities
Diabetes 67 (12) 115 (16) 46 (13)
Diabetes with end organ damage 41 (7) 53 (7) 77 (21)
Renal disease 68 (12) 48 (7) 79 (22)
Coronary artery disease 74 (13) 61 (8) 73 (20)
Congestive heart failure 155 (27) 127 (18) 132 (36)
Romano scorea
0 173 (30) 262 (36) 7 (2)
1–4 236 (41) 352 (49) 178 (49)
≥5 167 (29) 110 (15) 181 (49)
note. Data are no. (%), unless otherwise indicated. IQR, interquartile range.
a The Romano score is derived from the Charlson index, with higher scores indicative of more
comorbid illnesses.22 This score has been revised to predict mortality in Medicare patients.23,24




SSIs identified by traditional
surveillance (sensitivity, %)
SSIs identified by claims-
based surveillance
(sensitivity, %)
Hip arthroplasty ( )np 576
Superficial SSI 4 (0.7) 1 (25) 4 (100)
Deep and organ space SSI 10 (1.7) 2 (20) 10 (100)
Total SSI 14 (2.4) 3 (21) 14 (100)
Knee arthroplasty ( )np 724
Superficial SSI 3 (0.4) 0 (0) 3 (100)
Deep and organ space SSI 4 (0.6) 4 (100) 4 (100)
Total SSI 7 (1.0) 4 (57) 7 (100)
Vascular surgery ( )np 366
Superficial SSI 15 (4.1) 7 (47) 15 (100)
Deep and organ space SSI 14 (3.8) 9 (64) 14 (100)
Total SSI 29 (7.9) 16 (55) 29 (100)
control surveillance and medical record review triggered by
diagnosis and procedure codes. Our gold standard for de-
tection was all confirmed SSIs identified by either method.
We also assessed the performance of each individual code,
with the goal of removing codes that identified no confirmed
SSIs in our pilot study and either consistently captured con-
ditions other than SSI or were felt on further review to be
unrelated to SSI. In addition, we tested the performance of
more restricted code lists, on the basis of prior work (ICD-
9 diagnosis codes 996.66, 998.5, 998.51, and 998.59 for hip
and knee arthroplasty and 996.62, 998.5, 998.51, and 998.59
for vascular surgery).16,17
results
Four hospitals evaluated hip and knee arthroplasty, and 3
hospitals evaluated vascular surgery. The nonparticipating
hospital for vascular surgery had not performed prospective
SSI surveillance for this procedure during the study period.
Table 1 shows the patient characteristics for hip arthroplasty,
knee arthroplasty, and vascular surgery.
The numbers of eligible procedures and confirmed SSIs
are shown in Table 2 along with the sensitivity of both tra-
ditional surveillance and claims-based surveillance. We were
able to review flagged inpatient records on 71% of admissions
for hip arthroplasty, 76% of admissions for knee arthroplasty,
and 90% of admissions for vascular surgery. The remainder
of flagged inpatient records were at other hospitals. We were
able to review flagged outpatient/physician office records for
23% of visits following hip arthroplasty, 52% of visits fol-
lowing knee arthroplasty, and 57% of visits following vascular
surgery. Overall, 85% of vascular, 62% of hip, and 35% of
knee flags were submitted from inpatient admissions.
For hip arthroplasty, claims-based surveillance yielded a
4.7-fold increase in case detection for all SSIs and a 5-fold
increase in case detection of deep incisional and organ/space
SSIs. For knee arthroplasty, claims-based surveillance yielded
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table 3. Flag Rates and Surgical Site Infection (SSI) Confirmation Using Claims-Based Surveillance
No. of procedures flagged at
index hospital/no. of eligible
procedures (%)




Hospital A 12/248 4/12
Hospital B 8/160 3/8
Hospital C 17/127 5/17
Hospital D 5/41 2/5
Hospitals combined 42/576 (7.3) 14/42 (1 : 3)
Knee arthroplasty
Hospital E 20/302 2/20
Hospital F 8/266 2/8
Hospital G 6/126 3/6
Hospital H 0/30 NA
Hospitals combined 34/724 (4.7) 7/34 (1 : 5)
Vascular surgery
Hospital I 30/172 14/30
Hospital J 16/80 10/16
Hospital K 8/114 5/8
Hospitals combined 54/366 (14.8) 29/54 (1 : 2)
note. NA, not applicable.
a 1.8-fold increase in case detection for all SSIs, with no
increase in case detection of deep incisional and organ/space
SSIs. Even though we used a surveillance window of 365 days
for hip and knee arthroplasty, the median time from surgery
until deep incisional or organ/space SSI was 27 days for hip
arthroplasty and 18 days for knee arthroplasty, with 80% and
100% of deep incisional and organ/space SSIs captured within
60 days of surgery for hip arthroplasty and knee arthroplasty,
respectively. For vascular surgery, claims-based surveillance
yielded a 1.8-fold increase in case detection for all SSIs and
a 1.6-fold increase in case detection of deep incisional and
organ/space SSIs. The median time from surgery until deep
incisional or organ/space SSI was 18 days for vascular surgery.
In all 3 procedures, claims-based surveillance did not miss
any cases that had been captured by traditional surveillance.
The use of claims to trigger chart review led to confir-
mation of SSI in 1 out of 3 charts for hip arthroplasty, 1 out
of 5 charts for knee arthroplasty, and 1 out of 2 charts for
vascular surgery (Table 3). In contrast, infection prevention-
ists at the hospitals participating in this study reported an
average of 16 charts reviewed for every 1 confirmed SSI
(range, 9–50) based on traditional surveillance practices.
Use of the more restricted code lists (ICD-9 diagnosis codes
996.66, 998.5, 998.51, and 998.59 for hip and knee arthro-
plasty and 996.62, 998.5, 998.51, and 998.59 for vascular sur-
gery) resulted in identification of all of the SSIs detected by
the more inclusive lists (Table 4). Applying these restricted
lists of diagnosis codes, we found that the use of claims to
trigger chart review led to confirmation of SSI in 1 out of 2
charts for hip arthroplasty, 1 out of 4 charts for knee ar-
throplasty, and 2 out of 3 charts for vascular surgery.
After assessing the performance of each individual code,
we removed 9 of the 70 codes on the hip arthroplasty list,
11 of the 76 codes on the knee arthroplasty list, and 6 of the
29 codes on the vascular surgery list. This included the re-
moval of codes for incision and drainage that were used for
dermatologic issues (eg, carbuncle) for all procedures, as well
as codes associated with peritonitis (removed from vascular
surgery SSI code list) and codes associated with bone infec-
tions already classified elsewhere (removed from arthroplasty
SSI code lists). Our final procedure-specific SSI indicator
codes are shown in the appendix. Since we removed both
low-yield codes that did not flag any cases as well as infre-
quent codes that flagged conditions other than SSI, these
revisions had a minimal impact on the number of charts that
need to be reviewed for each confirmed SSI. We believe that
the larger list of codes deserves further evaluation.
discussion
Review of charts flagged by diagnosis and procedure codes
from Medicare claims identified more patients with chart-
validated SSI than routine surveillance following hip arthro-
plasty, knee arthroplasty, and vascular surgery. Given that this
study evaluated hospitals with significant resources dedicated
to surveillance, it is possible that the differences might be
even greater in hospitals with fewer resources.
We attribute the improved detection of our approach to
the fact that traditional surveillance by hospital infection pre-
vention programs relies on a variety of unproven screening
strategies to identify patients to evaluate for SSI, such as
screening of readmissions, review of daily microbiology re-
sults, and surgeon self-report. Often, hospitals do not have
an automated method for assessing whether wound cultures
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table 4. Sensitivity and Surgical Site Infection (SSI) Confirmation Using a Restricted List of Codes
Sensitivity (%)




ICD-9 codes 996.66, 998.5, 998.51, 998.59 14/14 (100) 14/26 (1 : 2)
Knee arthroplasty
ICD-9 codes 996.66, 998.5, 998.51, 998.59 7/7 (100) 7/27 (1 : 4)
Vascular surgery
ICD-9 codes 996.62, 998.5, 998.51, 998.59 29/29 (100) 29/44 (2 : 3)
note. ICD-9, International Classification of Diseases, Ninth Revision.
are derived from a surgical patient, with the result that in-
fection preventionists must review records on all patients with
a positive wound culture. Other infection prevention pro-
grams have opted to review records on all hospital readmis-
sions following surgery; however, this approach misses in-
fections diagnosed only in the outpatient setting. In addition,
traditional surveillance requires review of an average of 16
records for every confirmed SSI, 3–8 times more than what
we found for claims-based surveillance. Review of only charts
with specific coded diagnoses or procedures increased case
detection and limited chart review.
Our code lists were purposefully inclusive in order to max-
imize sensitivity and account for the possibility that other
codes would be preferentially used if certain codes were linked
to SSI surveillance. It is important to note, however, that this
strategy is associated with lower positive predictive values in
this and other studies.16-19 In fact, the low positive predictive
value of diagnosis and procedure codes has been used as an
argument against the use of administrative data for SSI sur-
veillance.18,19 Nevertheless, in practicality, this approach trans-
lates to a more efficient chart reviewed to confirmed SSI case
ratio and a higher capture of SSI compared with traditional
surveillance. While we found that more restricted code lists
performed better, it was important to assess code lists that
would not be affected by intentional use of alternative codes
and thus would provide a sustainable method for SSI sur-
veillance. The inclusiveness of our codes may also help ac-
count for variation in hospital coding practices.
These data support the use of coded diagnoses and pro-
cedures captured in claims to trigger chart review as the pri-
mary method of SSI surveillance for these 3 procedures. While
the inclusion of postoperative antibacterial use improves case
capture for some procedures, prior work by our team has
also shown that diagnosis and procedure codes alone can
detect SSIs in these procedures with a high sensitivity.16,17,20
Similar work has demonstrated the usefulness of this sur-
veillance method for detecting SSI following CABG.11,12 It is
important to note, however, the limitations of this study,
which include the use of claims from a single payer. While
only half of patients undergoing these procedures are insured
by Medicare,20,21 claims-based approaches to SSI surveillance
have been shown to work well when applied across payers
in individual hospital settings.11,16,20 Additional limitations in-
clude reviewing flagged records limited to the index insti-
tution where the surgery was performed and the fact that
coding practices in the 4 evaluated hospitals may not be rep-
resentative of other US hospitals. It will be important to assess
further the performance of our more inclusive lists of SSI
indicator codes on a national scale, including evaluation of
claims submitted from other hospitals and practices beyond
the institution where the surgery was performed.
The performance of these codes may vary depending on
the case mix of the patients. The tertiary care nature of the
hospitals in this study may have influenced the positive pre-
dictive value of our SSI indicator codes. It is possible that
the number of charts that would need to be reviewed for
each positive result could be different at institutions with
lower risk patient populations. Nevertheless, we do note that
our prior work on post-CABG SSIs showed a similar positive
predictive value in our pilot study in these same hospitals as
it did on the national scale.12
Finally, the utility of this method is reliant on the speed
at which codes are available at both the hospital and national
level; however, the required surveillance period for surgical
procedures that include prosthetic material includes 365 days
postoperatively, allowing ample time for coding, particularly
since the majority of SSI occur in the first 90 days.14
In summary, use of diagnosis and procedure codes to iden-
tify charts for review provides an efficient, labor-saving, and
improved method for primary SSI surveillance. This sur-
veillance strategy greatly improves capture of SSIs following
arthroplastic and vascular surgery, 3 SCIP procedures that
are a focus of national attention and public reporting for
reducing healthcare-associated infections. The use of rou-
tinely available diagnosis and procedure codes for surveillance
has the potential to improve SSI detection and reporting on
a local level and allow for more standardized interhospital
comparisons on a national level.
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appendix
supplemental tables
table a1. Hip Surgical Site Infection Indicator Codes
Code Code text
ICD-9 procedure
84.56 Insertion of cement spacer
86.01 Aspiration of skin and subcutaneous tissue (abscess, hematoma, seroma)
86.04 Other incision with drainage of skin and subcutaneous tissue
86.22 Excisional debridement of wound, infection, or burn
86.28 Nonexcisional debridement of wound, infection, or burn
ICD-9 diagnosis
686.8 Other specified local infections of skin and subcutaneous tissue
686.9 Unspecified local infection of skin and subcutaneous tissue
711.00 Pyogenic arthritis, site unspecified
711.05 Pyogenic arthritis, pelvis and thigh
711.08 Pyogenic arthritis, other specified sites
711.09 Pyogenic arthritis, multiple sites
711.40 Arthropathy associated with other bacterial diseases, site unspecified
711.45 Arthropathy associated with other bacterial diseases, pelvis and thigh
711.48 Arthropathy associated with other bacterial diseases, other specified sites
711.49 Arthropathy associated with other bacterial diseases, multiple sites
711.90 Unspecified infective arthritis, site unspecified
711.95 Unspecified infective arthritis, pelvis and thigh
711.98 Unspecified infective arthritis, other specified sites
711.99 Unspecified infective arthritis, multiple sites
730.00 Acute osteomyelitis, site unspecified
730.05 Acute osteomyelitis, pelvis and thigh
730.08 Acute osteomyelitis, other specified site
730.09 Acute osteomyelitis, multiple sites
730.10 Chronic osteomyelitis, site unspecified
730.15 Chronic osteomyelitis, pelvis and thigh
730.18 Chronic osteomyelitis, other specified site
730.19 Chronic osteomyelitis, multiple sites
730.20 Unspecified osteomyelitis, site unspecified
730.25 Unspecified osteomyelitis, pelvis and thigh
730.28 Unspecified osteomyelitis, other specified site
730.29 Unspecified osteomyelitis, multiple sites
730.90 Unspecified infection of bone, site unspecified
730.95 Unspecified infection of bone, pelvis and thigh
730.98 Unspecified infection of bone, other specified site
730.99 Unspecified infection of bone, multiple sites
996.60 Infection and inflammatory reaction due to unspecified device, implant
996.66 Infection and inflammatory reaction due to internal joint prosthesis
996.67 Infection and inflammatory reaction due to internal orthopedic device, implant
996.69 Infection and inflammation due to internal prosthetic implant
998.5 Postoperative infection, not elsewhere classified
998.51 Infected postoperative seroma
998.59 Other postoperative infection
998.6 Persistent postoperative fistula




10140 Incision and drainage of hematoma, seroma, or fluid collection
10160 Puncture aspiration of abscess, hematoma, bulla, or cyst
10180 Incision and drainage, complex, postoperative wound infection
12021 Treatment of superficial wound dehiscence; with packing
13160 Secondary closure of surgical wound or dehiscence, extensive or complicated
20000 Incision of soft tissue abscess, superficial
20005 Incision of soft tissue abscess, deep
26990 Incision and drainage, pelvis or hip joint area; deep abscess or hematoma
26991 Incision and drainage, pelvis or hip joint area; infected bursa
26992 Incision, bone cortex, pelvis and/or hip joint (osteomyelitis or bone abscess)
27030 Arthrotomy, hip, with drainage (eg, infection)
27070 Partial excision (eg, osteomyelitis or bone abscess); superficial (wing of ilium, greater trochanter of femur)
27090 Removal of hip prosthesis
27091 Removal of hip prosthesis, complicated, with or without spacer
27122 Acetabuloplasty, resection femoral head (girdlestone)
27301 Incision and drainage, deep abscess, bursa or hematoma, thigh or knee region
27303 Incision, deep, with opening of bone cortex, femur or knee (eg, osteomyelitis or bone abscess)
35860 Exploration for postoperative hemorrhage, thrombosis or infection, extremity
note. CPT, Current Procedural Terminology; ICD-9, International Classification of Diseases, Ninth Revision.
table a2. Knee Surgical Site Infection Indicator Codes
Code Code text
ICD-9 procedure
84.56 Insertion of cement spacer
86.01 Aspiration of skin and subcutaneous tissue (abscess, hematoma, seroma)
86.04 Other incision with drainage of skin and subcutaneous tissue
86.22 Excisional debridement of wound, infection, or burn
86.28 Nonexcisional debridement of wound, infection, or burn
ICD-9 diagnosis
686.8 Other specified local infections of skin and subcutaneous tissue
686.9 Unspecified local infection of skin and subcutaneous tissue
711.00 Pyogenic arthritis, site unspecified
711.05 Pyogenic arthritis, pelvis and thigh
711.06 Pyogenic arthritis, lower leg
711.08 Pyogenic arthritis, other specified sites
711.09 Pyogenic arthritis, multiple sites
711.40 Arthropathy associated with other bacterial diseases, site unspecified
711.45 Arthropathy associated with other bacterial diseases, pelvis and thigh
711.46 Arthropathy associated with other bacterial diseases, lower leg
711.48 Arthropathy associated with other bacterial diseases, other specified sites
711.49 Arthropathy associated with other bacterial diseases, multiple sites
711.90 Unspecified infective arthritis, site unspecified
711.95 Unspecified infective arthritis, pelvis and thigh
711.96 Unspecified infective arthritis, lower leg
711.98 Unspecified infective arthritis, other specified sites
711.99 Unspecified infective arthritis, multiple sites
730.00 Acute osteomyelitis, site unspecified
730.05 Acute osteomyelitis, pelvis and thigh
730.06 Acute osteomyelitis, lower leg
730.08 Acute osteomyelitis, other specified site
730.09 Acute osteomyelitis, multiple sites
730.10 Chronic osteomyelitis, site unspecified
730.15 Chronic osteomyelitis, pelvis and thigh
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table a2 (Continued)
Code Code text
730.16 Chronic osteomyelitis, lower leg
730.18 Chronic osteomyelitis, other specified site
730.19 Chronic osteomyelitis, multiple sites
730.20 Unspecified osteomyelitis, site unspecified
730.25 Unspecified osteomyelitis, pelvis and thigh
730.26 Unspecified osteomyelitis, lower leg
730.28 Unspecified osteomyelitis, other specified site
730.29 Unspecified osteomyelitis, multiple sites
730.90 Unspecified infection of bone, site unspecified
730.95 Unspecified infection of bone, pelvis and thigh
730.96 Unspecified infection of bone, lower leg
730.98 Unspecified infection of bone, other specified site
730.99 Unspecified infection of bone, multiple sites
996.60 Infection and inflammatory reaction due to unspecified device, implant
996.66 Infection and inflammatory reaction due to internal joint prosthesis
996.67 Infection and inflammatory reaction due to internal orthopedic device, implant
996.69 Infection and inflammation due to internal prosthetic implant
998.5 Postoperative infection, not elsewhere classified
998.51 Infected postoperative seroma
998.59 Other postoperative infection
998.6 Persistent postoperative fistula
CPT
10140 Incision and drainage of hematoma, seroma, or fluid collection
10160 Puncture aspiration of abscess, hematoma, bulla, or cyst
10180 Incision and drainage, complex, postoperative wound infection
12021 Treatment of superficial wound dehiscence; with packing
13160 Secondary closure of surgical wound or dehiscence, extensive or complicated
20000 Incision of soft tissue abscess, superficial
20005 Incision of soft tissue abscess, deep
27301 Incision and drainage, deep abscess, bursa or hematoma, thigh or knee region
27303 Incision, deep, with opening of bone cortex, femur or knee (eg, osteomyelitis or bone abscess)
27310 Arthrotomy, knee, with exploration, drainage or removal of foreign body (eg, infection)
27488 Removal, total knee prosthesis, with or without spacer placement
27603 Incision and drainage, leg or ankle, deep abscess or hematoma
27604 Incision and drainage, leg or ankle, infected bursa
27607 Incision (eg, osteomyelitis or bone abscess), leg or ankle
35860 Exploration for postoperative hemorrhage, thrombosis or infection, extremity
note. CPT, Current Procedural Terminology; ICD-9, International Classification of Diseases, Ninth Revision.
table a3. Vascular Surgical Site Infection Indicator Codes
Code Code text
ICD-9 procedure
54.0a Incision of abdominal wall (drainage of abscess)
54.19a Other laparotomy (drainage of intraperitoneal abscess or hematoma)
86.01 Aspiration of skin and subcutaneous tissue (abscess, hematoma, seroma)
86.04 Other incision with drainage of skin and subcutaneous tissue
86.22 Excisional debridement of wound, infection, or burn
86.28 Nonexcisional debridement of wound, infection, or burn
ICD-9 diagnosis
686.8 Other specified local infections of skin and subcutaneous tissue
686.9 Unspecified local infection of skin and subcutaneous tissue
996.60 Infection and inflammatory reaction due to unspecified device, implant, graft
996.62 Infection and inflammatory reaction due to vascular device, implant, graft
998.51 Infected postoperative seroma
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table a3 (Continued)
Code Code text
998.59 Other postoperative infection
998.6 Persistent postoperative fistula
CPT
10140 Incision and drainage of hematoma, seroma, or fluid collection
10160 Puncture aspiration of abscess, hematoma, bulla, or cyst
10180 Incision and drainage, complex, postoperative wound infection
12021 Treatment of superficial wound dehiscence; with packing
13160 Secondary closure of surgical wound or dehiscence, extensive or complicated
20000 Incision of soft tissue abscess, superficial
20005 Incision of soft tissue abscess, deep
35840a Exploration for postoperative hemorrhage, thrombosis or infection, abdomen
35903 Excision of infected graft; extremity
35907a Excision of infected graft; abdomen
note. CPT, Current Procedural Terminology; ICD-9, International Classification of Diseases, Ninth
Revision.
a Used only for central vascular procedures (ICD-9 procedure codes 38.14, 38.16, 38.34, 38.36,
38.37, 38.44, 38.64, 39.25, 39.26, and any combination of vascular procedures that include 1 of
these codes).
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